We have collected information about Biodegradable Nanoparticles For Cytosolic Delivery Of Therapeutics for you. Follow the links to find out details on Biodegradable Nanoparticles For Cytosolic Delivery Of Therapeutics.
https://www.sciencedirect.com/science/article/pii/S0169409X07000932
Aug 10, 2007 · Biodegradable nanoparticles for cytosolic delivery of therapeutics ... The efficiency of drug-carriers for cytosolic delivery of therapeutics is limited mainly by their interaction with cell membranes and the endosomal release of carriers. Most of the carriers including liposomes and polymeric NPs associate with the cell membrane and are ...Author: Jaspreet K. Vasir, Vinod D Labhasetwar
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002520/
Aug 10, 2007 · Many therapeutics require efficient cytosolic delivery either because the receptors for those drugs are located in the cytosol or their site of action is an intracellular organelle that requires transport through the cytosolic compartment. To achieve ...Author: Jaspreet K. Vasir, Vinod D Labhasetwar
https://www.ncbi.nlm.nih.gov/pubmed/17683826
Aug 10, 2007 · Biodegradable nanoparticles for cytosolic delivery of therapeutics. ... Many therapeutics require efficient cytosolic delivery either because the receptors for those drugs are located in the cytosol or their site of action is an intracellular organelle that requires transport through the cytosolic compartment. To achieve efficient cytosolic ...Author: Jaspreet K. Vasir, Vinod D Labhasetwar
https://www.sciencedirect.com/science/article/abs/pii/S0169409X07000932
Biodegradable nanoparticles for cytosolic ... Many therapeutics require efficient cytosolic delivery either because the receptors for those drugs are located in the cytosol or their site of action is an intracellular organelle that requires transport through the cytosolic compartment. To achieve efficient cytosolic delivery of therapeutics ...Author: Jaspreet K. Vasir, Vinod D Labhasetwar
https://www.researchgate.net/publication/6155362_Vasir_JK_Labhasetwar_V_Biodegradable_nanoparticles_for_cytosolic_delivery_of_therapeutics_Adv_Drug_Deliv_Rev_59_718-728
Vasir, J.K. & Labhasetwar, V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv. Drug Deliv. Rev. 59, 718-728
https://freepaper.me/downloads/abstract/10.1016/j.addr.2007.06.003
Biodegradable nanoparticles for cytosolic delivery of therapeutics☆ Many therapeutics require efficient cytosolic delivery either because the receptors for those drugs are located in the cytosol or their site of action is an intracellular organelle that requires transport through the cytosolic compartment.
https://www.deepdyve.com/lp/elsevier/biodegradable-nanoparticles-for-cytosolic-delivery-of-therapeutics-ihR5E3Kqle
Aug 10, 2007 · Biodegradable nanoparticles for cytosolic delivery of therapeutics Biodegradable nanoparticles for cytosolic delivery of therapeutics Vasir, Jaspreet K.; Labhasetwar, Vinod 2007-08-10 00:00:00 Many therapeutics require efficient cytosolic delivery either because the receptors for those drugs are located in the cytosol or their site of action is an intracellular organelle that requires ...
https://jnanobiotechnology.biomedcentral.com/articles/10.1186/1477-3155-9-55
Nov 28, 2011 · Biodegradable nanoparticles (NPs) are gaining increased attention for their ability to serve as a viable carrier for site specific delivery of vaccines, genes, drugs and other biomolecules in the body. They offer enhanced biocompatibility, superior drug/vaccine encapsulation, and convenient release profiles for a number of drugs, vaccines and biomolecules to be used in a variety of ...Author: Anil Mahapatro, Dinesh K Singh
https://link.springer.com/article/10.1007%2Fs11481-016-9692-7
Jul 02, 2016 · Despite the significant advances in neurological medicine, it remains difficult to treat ailments directly involving the brain. The blood brain barrier (BBB) is a tightly regulated, selectively permeable barrier that restricts access from the blood into the brain extracellular fluid (BEF). Many conditions such as tumors or infections in the brain are difficult to treat due to the fact that ...Author: Catherine DeMarino, Angela Schwab, Michelle Pleet, Allison Mathiesen, Joel M. Friedman, Nazira El-Ha...
https://www.researchgate.net/publication/304744601_Biodegradable_Nanoparticles_for_Delivery_of_Therapeutics_in_CNS_Infection
Request PDF Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection Despite the significant advances in neurological medicine, it remains difficult to treat ailments directly ...
Searching for Biodegradable Nanoparticles For Cytosolic Delivery Of Therapeutics?
You can just click the links above. The data is collected for you.
